This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Johannes Gutenberg-Universitaet Mainz. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovations of Hansjoerg Schild
Introduction
Hansjoerg Schild, an accomplished inventor based in Schwabenheim, Germany, has made significant contributions to the field of pharmaceuticals. With two patents to his name, his innovative work primarily addresses critical health challenges related to clostridial cytotoxins and vaccination methods.
Latest Patents
Hansjoerg Schild's latest patents showcase his dedication to advancing medical science. The first, titled "Medicament for LCT poisoning," is focused on preventing or alleviating poisoning caused by large clostridial cytotoxins, particularly toxins A and B. This innovative medicament includes at least one effector that acts as an inhibitor or activator of the autocatalytic protease activity of LCTs.
His second patent, "Preparation for vaccination, vaccination method and use of a vaccination preparation," details a pharmaceutical formulation that comprises at least one Toll-like receptor ligand and at least one peptide. This invention not only outlines the preparation but also discusses its application in vaccination methods.
Career Highlights
Hansjoerg Schild is affiliated with the Johannes Gutenberg University Mainz, where he leverages his expertise to drive innovation in pharmaceuticals. His role at this esteemed institution allows him to remain at the forefront of research and development in medical treatments.
Collaborations
Throughout his career, Hansjoerg Schild has collaborated with notable colleagues, including Tobias Warger and Markus Radsak. These partnerships have likely contributed to the enhancement and success of his innovative projects, fostering a rich environment of teamwork and shared knowledge.
Conclusion
In conclusion, Hansjoerg Schild stands out as a prominent inventor whose work has the potential to greatly impact the medical field. His ongoing dedication to innovation, exemplified by his recent patents, underscores the essential role of inventors in addressing urgent health concerns and advancing pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile